105 related articles for article (PubMed ID: 36684109)
1. Heterogeneous Responses to Mechanical Force of Prostate Cancer Cells Inducing Different Metastasis Patterns.
Liu Z; Wang L; Xu H; Du Q; Li L; Wang L; Zhang ES; Chen G; Wang Y
Adv Sci (Weinh); 2020 Aug; 7(15):1903583. PubMed ID: 32775149
[TBL] [Abstract][Full Text] [Related]
2. STAT3 mediates ECM stiffness-dependent progression in ovarian cancer.
Chenchen S; Xueqian Q; Yahui L; Yi Y; Hui Z; Lanning B; Min C; Yangyang H
Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38625514
[TBL] [Abstract][Full Text] [Related]
3. In Situ Engineering Cancer Mask to Immobilize Tumor Cells and Block Metastasis.
Zhang X; Li C; Zhu D; Mao H; Jiang X
Adv Healthc Mater; 2024 Apr; ():e2400742. PubMed ID: 38676706
[TBL] [Abstract][Full Text] [Related]
4. Current Understanding of Microbiomes in Cancer Metastasis.
Liu J; Luo F; Wen L; Zhao Z; Sun H
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980779
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria spatially and temporally modulate VSMC phenotypes via interacting with cytoskeleton in cardiovascular diseases.
Li J; Li X; Song S; Sun Z; Li Y; Yang L; Xie Z; Cai Y; Zhao Y
Redox Biol; 2023 Aug; 64():102778. PubMed ID: 37321061
[TBL] [Abstract][Full Text] [Related]
6. The molecular mechanisms of peptidyl-prolyl
Wu S; Zou Y; Tan X; Yang S; Chen T; Zhang J; Xu X; Wang F; Li W
Front Pharmacol; 2024; 15():1373446. PubMed ID: 38711994
[TBL] [Abstract][Full Text] [Related]
7. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
Meng M; Guo Y; Chen Y; Li X; Zhang B; Xie Z; Liu J; Zhao Z; Liu Y; Zhang T; Qiao Y; Shang B; Zhou Q
Cell Oncol (Dordr); 2024 Apr; 47(2):657-676. PubMed ID: 37924456
[TBL] [Abstract][Full Text] [Related]
8. Mechanotransduction pathways in regulating epithelial-mesenchymal plasticity.
Horta CA; Doan K; Yang J
Curr Opin Cell Biol; 2023 Dec; 85():102245. PubMed ID: 37804773
[TBL] [Abstract][Full Text] [Related]
9. PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.
Chen H; Yang W; Li Y; Ji Z
Cell Death Dis; 2023 Jul; 14(7):433. PubMed ID: 37454211
[TBL] [Abstract][Full Text] [Related]
10. A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression.
Li HL; Li QY; Jin MJ; Lu CF; Mu ZY; Xu WY; Song J; Zhang Y; Zhang SY
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1569-1585. PubMed ID: 33864521
[TBL] [Abstract][Full Text] [Related]
11. The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer.
Akrida I; Bravou V; Papadaki H
Mol Biol Rep; 2022 Oct; 49(10):10065-10076. PubMed ID: 35604626
[TBL] [Abstract][Full Text] [Related]
12. Pin1/YAP pathway mediates matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism.
Yang L; Li J; Zang G; Song S; Sun Z; Li X; Li Y; Xie Z; Zhang G; Gui N; Zhu S; Chen T; Cai Y; Zhao Y
Bioeng Transl Med; 2023 Jan; 8(1):e10375. PubMed ID: 36684109
[TBL] [Abstract][Full Text] [Related]
13. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis.
Dong Y; Zheng Q; Wang Z; Lin X; You Y; Wu S; Wang Y; Hu C; Xie X; Chen J; Gao D; Zhao Y; Wu W; Liu Y; Ren Z; Chen R; Cui J
J Hematol Oncol; 2019 Nov; 12(1):112. PubMed ID: 31703598
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
[No Abstract] [Full Text] [Related]
15. Matrix stiffness regulates epithelial-mesenchymal transition via cytoskeletal remodeling and MRTF-A translocation in osteosarcoma cells.
Dai J; Qin L; Chen Y; Wang H; Lin G; Li X; Liao H; Fang H
J Mech Behav Biomed Mater; 2019 Feb; 90():226-238. PubMed ID: 30384218
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
